(Q44251054)

English

Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

0 references

0 references

lymph node metastasis

1 reference

based on heuristic

inferred from title

author name string

Qinwen Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Xinwei Diao

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Jianguo Sun

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Zhengtang Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

312-317

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Localized prostate cancer: radiation or surgery?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Chemokines and their role in tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Involvement of chemokine receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

CXCL13 and CXCL12 in central nervous system lymphoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Matrix metalloproteinases: biologic activity and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Proteases in invasion: matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Risk of prostate carcinoma death in patients with lymph node metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Cause of death in men diagnosed with prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Prostate cancer-specific survival in men treated with hormonal therapy after failure of radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.01.006

7 January 2021

Identifiers

10.1016/J.UROLONC.2011.01.006

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44251054&oldid=2108913122"